ArticleFrontiers in psychiatry2025
Digitally-enhanced medication-assisted treatment for opioid use disorder: acceptability, engagement and treatment retention.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Implementation of a Mobile Digital Tool Supporting Medication for Opioid Use Disorder Treatment Improves Retention: Stepped-Wedge Cluster Randomized Controlled Trial.Journal of medical Internet research · 2025Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Opioid use disorder (OUD) is a persistent public health crisis, with medication for opioid use disorder (MOUD) significantly reducing overdose risk and improving outcomes. However, treatment adherence and retention remain critical challenges. Digital health tools offer promising solutions, yet their integration into MOUD programs has been limited. This study evaluates the implementation of Methods: This observational study assessed the adoption and impact of Results: Patient and clinician acceptance of the app was high, with 83.7% of patients who completed baseline acceptance survey expressing intent to use it. Early engagement-particularly self-monitoring and clinician-initiated messaging-was significantly associated with increased retention. Compared to historical data, 30-day retention improved by 12.2% across all clinics and by 13.2% in Arizona-based clinics. Patients with higher app engagement and more frequent clinician interactions had significantly greater odds of remaining in treatment. Conclusion: Digital tools such as
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.